• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Contraceptives Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 Product Image

Contraceptives Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • ID: 3067608
  • December 2014
  • Region: Global
  • 106 Pages
  • Transparency Market Research
North America dominated the global contraceptives market in 2013 due to high incidence rate of unintended pregnancies

FEATURED COMPANIES

  • Actavis, Inc.
  • Bayer AG
  • Church & Dwight Co., Inc.
  • CooperSurgical, Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • MORE

'Contraceptives Market (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, Sub-Dermal Contraceptive Implants, Contraceptive Vaginal Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020'

Contraceptives are defined as drugs and devices that help in preventing pregnancy. These devices also prevent spreading of sexually transmitted infection. Various awareness initiatives taken by market players is the major factor propelling the growth of contraceptives market. Bayer HealthCare, a major player in the contraceptives market, in coalition with 11 NGOs, organizes the World Contraception Day every year on September 26 to spread awareness about contraceptive methods, enabling young people to take right decision about their reproductive health.

This report provides in-depth analysis of the global contraceptives drugs and devices market. The stakeholders for this report include companies involved in the research and development, manufacturing and commercialization of contraceptive READ MORE >

Note: Product cover images may vary from those shown
North America dominated the global contraceptives market in 2013 due to high incidence rate of unintended pregnancies

FEATURED COMPANIES

  • Actavis, Inc.
  • Bayer AG
  • Church & Dwight Co., Inc.
  • CooperSurgical, Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • MORE

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Contraceptives Market
2.2 Comparative Analysis: Global Contraceptives Market, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Contraceptives Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 High incident rate of unintended pregnancies is leading to unmet contraceptive needs, hence driving the contraceptives market
3.2.1.2 Awareness programs by government and NGOs are promoting the use of contraceptives globally
3.2.1.3 Implementation of the Patient Protection Act or the Affordable Care Act increased the use of contraceptives in North America
3.2.2 Market Restraints
3.2.2.1 Side effects associated with the use of contraceptive drugs and devices induce people to opt for natural and permanent contraceptive methods
3.2.2.2 Rising prevalence of infertility among women and aging population are limiting the use of contraceptives
3.2.2.3 Ethical and social issues restrict the use or subsidies on contraceptives in some countries
3.2.3 Market Opportunities
3.2.3.1 Presence of large unmet contraceptive needs in emerging Asian and African Economies would drive the contraceptives market
3.2.3.2 Presence of strong contraceptive pipeline would support the global contraceptives market during the forecast period
3.3 Porter’s Five Forces Analysis: Global Contraceptives Market
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
3.5 Competitive Landscape: Global Contraceptives Market, by Key Players
3.5.1 Heat Map Analysis for Key Market Players: Global Contraceptive Drugs Market
3.5.2 Heat Map Analysis for Key Market Players: Global Contraceptive Devices Market

Chapter 4 Global Contraceptives Market, by Product Type
4.1 Introduction
4.1.1 Comparative Analysis: Global Contraceptives Market Revenue, by Product Type, 2013 & 2020 (%)
4.2 Contraceptive Drugs
4.2.1 Global Contraceptive Drugs Market Revenue, by Drug Type, 2012 - 2020 (USD Million)
4.2.2 Oral Contraceptive Pills
4.2.2.1 Global Oral Contraceptive Pills Market Revenue, 2012 - 2020 (USD Million)
4.2.3 Contraceptive Injectables
4.2.3.1 Global Contraceptive Injectables Market Revenue, 2012 - 2020 (USD Million)
4.2.4 Topical Contraceptives
4.2.4.1 Global Topical Contraceptives Market Revenue, 2012 - 2020 (USD Million)
4.3 Contraceptive Devices
4.3.1 Comparative Analysis: Global Contraceptive Devices Market, by Device Type, 2013 & 2020 (%)
4.3.2 Male Contraceptive Devices (Male Condoms)
4.3.2.1 Global Male Contraceptive Devices Market Revenue, 2012 - 2020 (USD Million)
4.3.2.2 Competitive Landscape: Global Male Contraceptive Devices (Male Condoms) Segment
4.3.3 Female Contraceptive Devices
4.3.3.1 Global Female Contraceptive Devices Market Revenue, by Device Type, 2012 - 2020 (USD Million)
4.3.3.2 Female Condoms
4.3.3.2.1 Global Female Condoms Market Revenue, 2012 - 2020 (USD Million)
4.3.3.3 Contraceptive Diaphragms
4.3.3.3.1 Global Contraceptive Diaphragms Market Revenue, 2012 - 2020 (USD Million)
4.3.3.4 Contraceptive Sponges
4.3.3.4.1 Global Contraceptive Sponges Market Revenue, 2012 - 2020 (USD Million)
4.3.3.5 Contraceptive Vaginal Rings
4.3.3.5.1 Global Contraceptive Vaginal Rings Market Revenue, 2012 - 2020 (USD Million)
4.3.3.6 Intrauterine Devices
4.3.3.6.1 Global Intrauterine Devices Market Revenue, 2012 - 2020 (USD Million)
4.3.3.7 Subdermal Contraceptive Implants
4.3.3.7.1 Global Subdermal Implants Market Revenue, 2012 - 2020 (USD Million)
4.3.3.8 Non-Surgical Permanent Contraception Devices
4.3.3.8.1 Global Non-Surgical Permanent Contraception Devices Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 Global Contraceptives Market, by Geography
5.1 Overview
5.1.1 Global Contraceptives Market Revenue, by Geography, 2012 - 2020 (USD Million)
5.2 North America
5.2.1 North America Contraceptives Market Revenue, 2012 - 2020 (USD Million)
5.2.2 North America Contraceptives Market, by Products (Drugs & Devices), 2012 - 2020 (USD Million)
5.3 Europe
5.3.1 Europe Contraceptives Market Revenue, 2012 - 2020 (USD Million)
5.3.2 Europe Contraceptives Market, by Products (Drugs & Devices), 2012 - 2020 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Contraceptives Market Revenue, 2012 - 2020 (USD Million)
5.4.2 Asia Pacific Contraceptives Market, by Products (Drugs & Devices), 2012 - 2020 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World Contraceptives Market Revenue, 2012 - 2020 (USD Million)
5.5.2 Rest of the World Contraceptives Market, by Products (Drugs & Devices), 2012 - 2020 (USD Million)

Chapter 6 Recommendations
6.1 Investing in Emerging Economies such as India and China and Underdeveloped African Economies
6.2 Making Rigorous R&D Initiatives
6.3 Investing in Marketing Campaigns to Elevate Customer Awareness
6.4 Tracking Patent Expiration of Branded Products

Chapter 7 Company Profiles
7.1 Actavis, Inc.
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 Church & Dwight Co., Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 CooperSurgical, Inc.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Mayer Laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Reckitt Benckiser plc
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments
7.10 The Female Health Company
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments

List of Figures:
FIG. 1 Contraceptives Market Segmentation
FIG. 2 Global Contraceptive Drugs Market, by Product, 2013 (USD Million)
FIG. 3 Global Contraceptive Devices Market, by Product, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global Contraceptives Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Number of People Aged 60 or Over: Developed and Developing Countries, 1950 - 2050
FIG. 6 Average Percentage of Women with Unmet Contraceptive Needs in the Southeast Asian, South Central Asian and Sub-Saharan African countries, 2011 (%)
FIG. 7 Porter’s Five Forces Analysis: Global Contraceptives Market
FIG. 8 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
FIG. 9 Heat Map Analysis for Key Market Players: Global Contraceptive Drugs Market
FIG. 10 Heat Map Analysis for Key Market Players: Global Contraceptive Devices Market
FIG. 11 Comparative Analysis of the Global Contraceptives Market Revenue, by Product Type, 2013 & 2020 (%)
FIG. 12 Global Oral Contraceptive Pills Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 Global Contraceptive Injectables Market Revenue, 2012 - 2020 (USD Million)
FIG. 14 Global Topical Contraceptives Market Revenue, 2012 - 2020 (USD Million)
FIG. 15 Comparative Analysis of the Global Contraceptive Devices Market, by Device Type, 2013 & 2020 (%)
FIG. 16 Global Male Contraceptive Devices Market Revenue, 2012 - 2020 (USD Million)
FIG. 17 Global Female Condoms Market Revenue, 2012 - 2020 (USD Million)
FIG. 18 Global Contraceptive Diaphragms Market Revenue, 2012 - 2020 (USD Million)
FIG. 19 Global Contraceptive Sponges Market Revenue, 2012 - 2020 (USD Million)
FIG. 20 Global Contraceptive Vaginal Rings Market Revenue, 2012 - 2020 (USD Million)
FIG. 21 Global Intrauterine Devices Market Revenue, 2012 - 2020 (USD Million)
FIG. 22 Global Sub-dermal Implants Market Revenue, 2012 - 2020 (USD Million)
FIG. 23 Global Non-Surgical Permanent Contraceptive Devices Market Revenue, 2012 - 2020 (USD Million)
FIG. 24 North America Contraceptives Market Revenue, 2012 - 2020 (USD Million)
FIG. 25 Europe Contraceptives Market Revenue, 2012 - 2020 (USD Million)
FIG. 26 Asia Pacific Contraceptives Market Revenue, 2012 - 2020 (USD Million)
FIG. 27 Rest of the World Contraceptives Market Revenue, 2012 - 2020 (USD Million)
FIG. 28 Actavis, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 29 Bayer AG: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 30 Church & Dwight Co., Inc.: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 31 CooperSurgical, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 32 Merck & Co., Inc.: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 33 Pfizer, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 34 Reckitt Benckiser Group plc: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 35 Teva Pharmaceutical Industries Ltd.: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 36 The Female Health Company: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables:
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Contraceptives Market
TABLE 3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
TABLE 4 Global Contraceptive Drugs Market Revenue, by Drug Type, 2012 - 2020 (USD Million)
TABLE 5 Global Female Contraceptive Devices Market Revenue, by Device Type, 2012 - 2020 (USD Million)
TABLE 6 Global Intrauterine Devices Market Revenue, by Types, 2012 - 2020 (USD Million)
TABLE 7 Global Contraceptives Market Revenue, by Geography, 2012 - 2020 (USD Million)
TABLE 8 North America Contraceptives Market Revenue, by Types (Drugs and Devices), 2012 - 2020 (USD Million)
TABLE 9 Europe Contraceptives Market Revenue, by Types (Drugs and Devices), 2012 - 2020 (USD Million)
TABLE 10 Asia Pacific Contraceptives Market Revenue, by Products (Drugs and Devices), 2012 - 2020 (USD Million)
TABLE 11 Rest of the World Contraceptives Market Revenue, by Products (Drugs and Devices), 2012 - 2020 (USD Million)

Note: Product cover images may vary from those shown
North America dominated the global contraceptives market in 2013 due to high incidence rate of unintended pregnancies

FEATURED COMPANIES

  • Actavis, Inc.
  • Bayer AG
  • Church & Dwight Co., Inc.
  • CooperSurgical, Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • MORE

Contraceptives are drugs and devices that are used to prevent pregnancy and sexually transmitted infections. Growing awareness about contraceptives and their offered advantage in preventing pregnancy and sexually transmitted infections (STIs) is the major factor that is driving the contraceptives market. Market players such as Bayer Healthcare in coalition with several NGOs organizes World Contraception Day on September 26th every year, to spread awareness about contraceptives and their benefits. Such awareness drives help the public in making right decisions about their sexual and reproductive health.

Based on the types of products, the global contraceptives market has been categorized into contraceptive drugs and devices. Contraceptive drugs are further classified as contraceptive pills, topical contraceptives and contraceptive injectables. Contraceptive pills dominated the overall drugs segment owing to their high usage in North America and high efficiency in preventing pregnancy and convenience of use. Based on the type of devices, the contraceptives market is further categorized into male and female contraceptive devices. Female contraceptive devices dominated this segment due to their low cost, ease of usage and high potential in the prevention of pregnancy along with sexually transmitted infections. Female devices market is further differentiated into seven segments: female condoms, intrauterine devices, contraceptive sponges, contraceptive diaphragms, contraceptive patches, subdermal contraceptive implants and non-surgical permanent contraceptive devices. The intrauterine devices (IUD) sub-segment held the largest share of the female contraceptive devices segment in 2013 due to high usage rates in Europe and China. However, the introduction of other effective female contraception devices such as sub-dermal contraceptive implants such as Sino-implant (II), female condom FC2 and non-surgical permanent contraception devices such as Essure, which suits the buying preferences of contraceptive users in Asia, coupled with the rising acceptance of vaginal rings, would reduce the market share of intrauterine devices during the forecast period.

Geographically, the global contraceptives market has been differentiated into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America dominated the global contraceptives market in 2013 due to high incidence rate of unintended pregnancies, availability of favorable reimbursement policies after implementation of the Affordable Care Act and increased use of emergency contraceptive pills and oral contraceptive pills. On the other hand, Asia Pacific is estimated as the most opportunistic market during the forecast period due to strong economic growth in countries such as India, China, Singapore, Philippines, Australia and others. This in turn, has led to increased awareness about the use of contraception for pregnancy prevention and STIs, rising disposable income and demand for healthy life, which is increasing the adoption rate of contraceptives in Asia Pacific.

The global contraceptives market is characterized by the presence of major companies such as Actavis, Inc., Bayers AG, Church & Dwight, Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd. and The Female Health Company. These market players are engaged in growth strategies such as acquisitions, marketing of products (providing free samples or contraceptives in reduced prices) and creating various awareness programs to increase market share and sustain in the highly competitive contraceptives market.

Note: Product cover images may vary from those shown
North America dominated the global contraceptives market in 2013 due to high incidence rate of unintended pregnancies

- Actavis, Inc.
- Bayer AG
- Church & Dwight Co., Inc.
- CooperSurgical, Inc.
- Mayer Laboratories, Inc.
- Merck & Co., Inc.
- Pfizer, Inc.
- Reckitt Benckiser plc
- Teva Pharmaceutical Industries Ltd.
- The Female Health Company

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

AbbVie Ltd. Sigma-Aldrich Corporation Bruker Corporation Raumedic AG Ferring Pharmaceuticals B.V. Baxter International Inc.